[HTML][HTML] Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and …

M Huhn, A Nikolakopoulou, J Schneider-Thoma… - The Lancet, 2019 - thelancet.com
Background Schizophrenia is one of the most common, burdensome, and costly psychiatric
disorders in adults worldwide. Antipsychotic drugs are its treatment of choice, but there is …

[HTML][HTML] Psychosis in Alzheimer disease—mechanisms, genetics and therapeutic opportunities

Z Ismail, B Creese, D Aarsland, HC Kales… - Nature Reviews …, 2022 - nature.com
Psychosis is a common and distressing symptom in people with Alzheimer disease, and few
safe and effective treatments are available. However, new approaches to symptom …

[HTML][HTML] Integrated mental health services for the developmental period (0 to 25 years): a critical review of the evidence

P Fusar-Poli - Frontiers in Psychiatry, 2019 - frontiersin.org
Background: The developmental period from 0 to 25 years is a vulnerable time during which
children and young people experience many psychosocial and neurobiological changes …

Psychotic disorders in late life: a narrative review

RR Tampi, J Young, R Hoq… - Therapeutic …, 2019 - journals.sagepub.com
Psychotic disorders are not uncommon in late life. These disorders often have varied
etiologies, different clinical presentations, and are associated with significant morbidity and …

[HTML][HTML] Characteristics of very late-onset schizophrenia-like psychosis as prodromal dementia with Lewy bodies: a cross-sectional study

H Kanemoto, Y Satake, T Suehiro, D Taomoto… - Alzheimer's Research & …, 2022 - Springer
Background This study aimed to identify cases of potential prodromal DLB in very late-onset
schizophrenia-like psychosis (VLOSLP), using indicative biomarkers of dementia with Lewy …

Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta …

M Huhn, A Nikolakopoulou, J Schneider-Thoma… - Focus, 2020 - Am Psychiatric Assoc
Background: Schizophrenia is one of the most common, burdensome, and costly psychiatric
disorders in adults worldwide. Antipsychotic drugs are its treatment of choice, but there is …

Antipsychotic treatment in elderly patients on polypharmacy with schizophrenia

M Stuhec - Current Opinion in Psychiatry, 2022 - journals.lww.com
Elderly patients with SCH on polypharmacy are less frequently studied, although they
represent many patients with SCH. Different potentially inappropriate medication lists and …

Overview of late-onset psychoses

DP Devanand, DV Jeste, TS Stroup… - International …, 2024 - cambridge.org
Background: Several etiologies can underlie the development of late-onset psychosis,
defined by first psychotic episode after age 40 years. Late-onset psychosis is distressing to …

Association between risk of dementia and very late-onset schizophrenia-like psychosis: a Swedish population-based cohort study

J Stafford, J Dykxhoorn, A Sommerlad… - Psychological …, 2023 - cambridge.org
BackgroundAlthough the incidence of psychotic disorders among older people is
substantial, little is known about the association with subsequent dementia. We aimed to …

Neuroinflammation in late-onset schizophrenia: viewing from the standpoint of the microglia hypothesis

A Monji, Y Mizoguchi - Neuropsychobiology, 2022 - karger.com
Schizophrenia develops mainly in adolescence, but late-onset schizophrenia (LOS) is not
uncommon. According to the international consensus, schizophrenia which develops over …